Clinical Spectrum of VCP Myopathy, Paget Disease, and fronTotemporal Dementia: Experimental Models and Potential Treatments
暂无分享,去创建一个
Charles D. Smith | D. Wallace | V. Kimonis | J. Vesa | V. Caiozzo | A. Nalbandian | Mallikarjun Badadani | G. Watts | E. Dec | B. Martin | Eric Dec
[1] M. Rossor,et al. A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes , 2011, Journal of Neurology.
[2] D. Wallace,et al. VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease , 2010, PloS one.
[3] Takeo Kato,et al. Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.
[4] F. Mastaglia,et al. Two Australian families with inclusion-body myopathy, Paget’s disease of bone and frontotemporal dementia: Novel clinical and genetic findings , 2010, Neuromuscular Disorders.
[5] A. Wright,et al. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. , 2010, Human molecular genetics.
[6] K. Ess. Tuberous sclerosis complex: a brave new world? , 2010, Current opinion in neurology.
[7] William D Fraser,et al. Genome wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone , 2010, Nature Genetics.
[8] J. Ju,et al. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system , 2010, Autophagy.
[9] D. Piwnica-Worms,et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease , 2009, The Journal of cell biology.
[10] Charles D. Smith,et al. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts , 2009, Neuromuscular Disorders.
[11] M. Diaz-Meco,et al. p62 at the Crossroads of Autophagy, Apoptosis, and Cancer , 2009, Cell.
[12] M. Latterich,et al. Hereditary Inclusion Body Myopathy-Linked p97/VCP Mutations in the NH2 Domain and the D1 Ring Modulate p97/VCP ATPase Activity and D2 Ring Conformation , 2009, Molecular and Cellular Biology.
[13] N. Bresolin,et al. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation , 2009, Neurobiology of Aging.
[14] K. Claeys,et al. Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia , 2009, Neuromuscular Disorders.
[15] C. Smart,et al. Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[16] A. Djamshidian,et al. A novel mutation in the VCP gene (G157R) in a german family with inclusion‐body myopathy with paget disease of bone and frontotemporal dementia , 2009, Muscle & nerve.
[17] V. Kimonis,et al. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. , 2008, Biochimica et biophysica acta.
[18] M. Koenig,et al. Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex , 2008, Journal of child neurology.
[19] A. Pestronk,et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[20] N. Cairns,et al. ALS and FTLD: two faces of TDP‐43 proteinopathy , 2008, European journal of neurology.
[21] Junmin Peng,et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration , 2008, Journal of neurochemistry.
[22] G. Magnani,et al. Inclusion body myopathy, Paget’s disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling , 2008, Clinical genetics.
[23] P. Hartikainen,et al. Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions Visualized With Ubiquitin-Binding Protein p62 Immunohistochemistry , 2008, Journal of neuropathology and experimental neurology.
[24] Charles D. Smith,et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia , 2008, American journal of medical genetics. Part A.
[25] A. Kakizuka. Roles of VCP in human neurodegenerative disorders. , 2008, Biochemical Society transactions.
[26] A. Broccolini,et al. An Italian family with inclusion‐body myopathy and frontotemporal dementia due to mutation in the VCP gene , 2008, Muscle & nerve.
[27] T. Hoppe. Less is more: how protein degradation regulates muscle development. , 2008, Ernst Schering Foundation symposium proceedings.
[28] D. Drachman,et al. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia , 2007, Clinical genetics.
[29] A. Danek,et al. Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein. , 2007, Clinical neuropathology.
[30] J. Schneider,et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.
[31] Sara E. Miller,et al. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. , 2007, Human molecular genetics.
[32] Hanns Lochmüller,et al. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy , 2007, Nature Cell Biology.
[33] G. Warren,et al. Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. , 2007, Biochemical and biophysical research communications.
[34] E. Wanker,et al. Pathological consequences of VCP mutations on human striated muscle. , 2007, Brain : a journal of neurology.
[35] N. Cairns,et al. TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations , 2007, Journal of neuropathology and experimental neurology.
[36] Charles D. Smith,et al. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) , 2007, Genetics in Medicine.
[37] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[38] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[39] C. Duyckaerts,et al. Valosin-containing protein gene mutations , 2006, Neurology.
[40] Charles D. Smith,et al. Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations , 2006, Journal of neuropathology and experimental neurology.
[41] S. Dalal,et al. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. , 2006, Human molecular genetics.
[42] E. Hol,et al. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system. , 2006, Journal of Alzheimer's disease : JAD.
[43] F. Zimprich,et al. Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene , 2005, Neurology.
[44] V. Kimonis,et al. Autosomal Dominant Inclusion Body Myopathy, Paget Disease of Bone, and Frontotemporal Dementia , 2005, Alzheimer disease and associated disorders.
[45] Jacques P. Brown,et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. , 2005, The New England journal of medicine.
[46] K. Fliessbach,et al. Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.
[47] T. Hoppe,et al. Regulation of the Myosin-Directed Chaperone UNC-45 by a Novel E3/E4-Multiubiquitylation Complex in C. elegans , 2004, Cell.
[48] L. Hocking,et al. Novel UBA Domain Mutations of SQSTM1 in Paget's Disease of Bone: Genotype Phenotype Correlation, Functional Analysis, and Structural Consequences , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[49] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[50] A. Pestronk,et al. Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes , 2003, Neuromuscular Disorders.
[51] K. Okamoto,et al. Vacuole-creating protein in neurodegenerative diseases in humans , 2003, Neuroscience Letters.
[52] L. Hocking,et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. , 2002, Human molecular genetics.
[53] W. Engel,et al. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms , 2002, Current opinion in neurology.
[54] K. Sakamoto. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. , 2002, Molecular genetics and metabolism.
[55] I. Kanazawa,et al. Distal myopathy with rimmed vacuoles: Novel mutations in the GNE gene , 2002, Neurology.
[56] Ruth Geiss-Friedlander,et al. Protein Dislocation from the Endoplasmic Reticulum – Pulling Out the Suspect , 2002, Traffic.
[57] K. Fröhlich,et al. AAA-ATPase p97/Cdc48p, a Cytosolic Chaperone Required for Endoplasmic Reticulum-Associated Protein Degradation , 2002, Molecular and Cellular Biology.
[58] Mark A. Levenstien,et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. , 2001, Molecular genetics and metabolism.
[59] M. Hetzer,et al. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly , 2001, Nature Cell Biology.
[60] S. Jentsch,et al. Mobilization of Processed, Membrane-Tethered SPT23 Transcription Factor by CDC48UFD1/NPL4, a Ubiquitin-Selective Chaperone , 2001, Cell.
[61] W. Kamphorst,et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.
[62] Tsviya Olender,et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy , 2001, Nature Genetics.
[63] Chou-Chi H. Li,et al. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation , 2001, Nature Cell Biology.
[64] A. Wilkinson,et al. AAA+ superfamily ATPases: common structure–diverse function , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[65] J. Trojanowski,et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia , 2001, Annals of neurology.
[66] Murray Grossman,et al. Quantitative neurohistological features of frontotemporal degeneration , 2000, Neurobiology of Aging.
[67] S. Leal,et al. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone , 2000, Genetics in Medicine.
[68] D. Pappin,et al. A complex of mammalian Ufd1 and Npl4 links the AAA‐ATPase, p97, to ubiquitin and nuclear transport pathways , 2000, The EMBO journal.
[69] W. Baumeister,et al. AAA-ATPases at the crossroads of protein life and death , 1999, Nature Cell Biology.
[70] D. Geschwind,et al. Tau Mutations in Frontotemporal Dementia , 1999, Dementia and Geriatric Cognitive Disorders.
[71] E V Koonin,et al. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. , 1999, Genome research.
[72] A Klug,et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[73] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[74] Hisao Kondo,et al. Syntaxin 5 Is a Common Component of the NSF- and p97-Mediated Reassembly Pathways of Golgi Cisternae from Mitotic Golgi Fragments In Vitro , 1998, Cell.
[75] M. Latterich,et al. The AAA team: related ATPases with diverse functions. , 1998, Trends in cell biology.
[76] Hisao Kondo,et al. p47 is a cofactor for p97-mediated membrane fusion , 1997, Nature.
[77] K. Boone,et al. A study of the Lund‐Manchester research criteria for frontotemporal dementia , 1997, Neurology.
[78] Raymond Scott Turner,et al. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia , 1996, Annals of neurology.
[79] F. Confalonieri,et al. A 200‐amino acid ATPase module in search of a basic function , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[80] H. Lassmann,et al. Cytoskeleton pathology in Alzheimer's disease and related disorders. , 1991, Journal of neural transmission. Supplementum.
[81] Z. Argov,et al. “Rimmed vacuole myopathy” sparing the quadriceps A unique disorder in iranian jews , 1984, Journal of the Neurological Sciences.